AI assistant
Valereum Plc — Major Shareholding Notification 2025
Jul 29, 2025
10329_mrq_2025-07-29_fbc1129d-0905-4645-8da6-ed79826d2102.html
Major Shareholding Notification
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 8935S
Valereum PLC
29 July 2025
29/07/25

Valereum Plc
("Valereum", "VLRM" or the "Company")
Reduction of Holding in London BTC Company Limited
&
Change of Director Details
Valereum Plc (AQSE: VLRM) announces that it has reduced its shareholding in London BTC Company Limited, previously named Vinanz Limited ("Vinanz") as part of its capital allocation and investment strategy.
Valereum's holding in Vinanz has decreased from 27,325,171 to 15,400,171 shares, following the disposal of 11,925,000 shares ("Sale Shares"). The total proceeds from the disposal of the Sale Shares amounted to £1,755,641. Based on the original valuation of £0.01 per share, at which the Company received these shares as consideration for the sale of certain assets to Vinanz during 2023 (valuing the Sale Shares at £119,250), the Company has realised a gross profit of £1,636,391 from this disposal.
Change of Director Details
The Company also announced that Chairman, James Formolli, has changed his name by deed poll to his stage name, James Bannon, by which he is better known.
For further information, please contact:
| Valereum Plc Peter Sekhon, Investor Relations / Business Development Manager Engage with the company directly |
Tel: +44 7938 767319 Investor Hub |
| Fortified Securities ## Guy Wheatley |
Tel: +44 203 4117773 |
| AQSE Corporate Adviser First Sentinel Corporate Finance Brian Stockbridge |
Tel: +44 20 3855 5551 |
The Directors of the Company accept responsibility for the contents of this announcement.
For more information, please visit the Company's website at www.vlrm.com or to engage with the Valereum Plc management team, navigate to our Interactive Investor hub here: Sign Up
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NEXPKFBDNBKBOOB